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1. Introduction 
Aromatic and olefinic compounds can be trans- 
formed by microsomal mono-oxygenase(s) (MO) (EC 
1.14.1.1) to epoxides which represent elec trophilically 
reactive species. Accordingly, spontaneous binding of 
such epoxides to DNA, RNA and protein has been 
observed. Such alterations of important biomacro- 
molecules can involve disturbancies of the ordered 
sequences and interrelationships of biochemical 
events in a cell in such a way as to lead to mutageni- 
city, carcinogenicity or cell necrosis (for a review 
see [l] ). In the subcellular compartment were these 
epoxides are formed, the endoplasmatic reticulum, 
they can be metabolized by epoxide hy.lratase(s) 
(EH) (EC 4.2.1.63) to much less reactive dihydrodiols 
(for a review see [2] ; for reactivation of a dihydrod- 
iol by epoxidation at another site, and inactivation 
of the resulting mixed dihydrodiol-epoxide by 
epoxide hydratase-catalyzed transformation to a 
tetrahydrotetrol see [3,4]). Induction of EH would 
therefore be of great experimental and possibly 
practical interest, especially if MO responsible for 
the formation of epoxides, was not concomitantly 
induced. However, several (unpublished) observa- 
tions in the rat such as a virtually identical ontogen- 
etic development of EH (determined with [3 Hlstyrene 
oxide as substrate) and MO (determined with amino- 
pyrine as substrate): 2-3-fold higher EH levels in 
adult male than in female but no sex difference in 
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young rats corresponding to what is known for MO 
with respect to a great number of substrates [5] ; 
and induction of EH by representatives of 3 
distinctly different groups [6] of MO inducers 
(phenobarbital, 3-methylcholanthrene, pregnenolone 
16~arbonitrile) indicated that possibly anything 
that switches on the synthesis of EH may concomit- 
antly do so with respect to (a rate limiting entity 
of the multicomponent) MO. Since the stage of 
ontogenetic development required to allow induc- 
tion would not necessarily be the same for EH and 
MO if above observations were coinicental rather 
than really due to a common biosynthetic control 
of EH and MO, transplacental effects of potential 
inducing agents on EH and MO were investigated in 
this study. Several reports have indicated the presence 
of more than one EH [7] and MO [6,8-l l] in liver 
microsomal fractions. In the present investigation 
EH is assayed with 7- [3 H] styrene oxide and MO with 
benzo(a)pyrene as substrate. It had been shown in 
previous studies that increases in specific activity 
during solubilization and purification of EH were 
identical with epoxides derived from polycyclic 
aromdtic hydrocarbons and with styrene oxide as 
substrate [7] , and that the former effectively 
inhibited the hydration of the latter [ 121 suggesting 
that the same enzyme(s) is responsible for their 
hydration. 
2. Material and methods 
Female Sprague-Dawley rats (250-350 g) were 
kept together with males (200-300 g) during one 
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night immediately after the day of littering. The fetal 
ages referred to in this paper are based on counting 
the day thereafter as one day after copulation. 
Stomach tubes were used for transplacental treat- 
ment with potential inducers. At the time points 
indicated the pregnant rats were killed by a blow on 
the head, fetuses removed and livers of each litter 
were pooled in 2 vol of ice-cold 0.25 M sucrose con- 
taining 10 mM phosphate buffer pH 7.4. Homogeniza- 
tion was done in Potter-Elvehjem homogenizers with 
a Teflon pestle. Since in preliminary experiments 
heavy losses of microsomal yield were observed after 
8000 g centrifugation (cf. also [ 131) unbroken cells 
and nuclei were removed by a centrifugation at 
800 g for 15 min and the resulting supernatant used 
for the preparation of a crude microsomal pellet by 
centrifugation at 100 000 g for 1 hr. The pellets 
were resuspended in one half of the vol of the original 
homogenate of 10 mM phosphate buffer pH 7.4. MO 
was assayed with benzo(a)pyrene as substrate. Due 
to the instability of epoxides derived from aromatic 
compounds, no assay for quantitating the formation 
of arene oxides is available. Arene oxides in microsom- 
al preparations, besides undergoing enzymatic hydra- 
tion and spontaneous binding to tissue components, 
rearrange non-enzymatically to phenols [ 141. Since 
several MO’s may be present in the endoplasmic 
reticulum [6,8-l l] differentially involved in oxida- 
tive metabolism at different positions of the benzo(a)- 
pyrene molecule a dual assay was developed 
essentially by combining a) the method of Nebert 
and Celboin [ 151 and b) a modification (to be 
described in detail elsewhere) of that of Hayakawa 
and Udenfriend [ 161 with an increased sensitivity 
allowing determinations in fetal liver preparations 
from non-induced animals. The former method 
measures the major terminal microsomal metabolite, 
3_hydroxybenzo(a)pyrene and (possibly) also some 
other phenolic metabolites fluorimetrically. Pertinant 
results are labelled ‘3-OHBP’ in this study. The latter 
method using [3 H] benzo(a)pyrene measures mono- 
oxygenase activity with respect to any position at 
the benzo(a)pyrene molecule although possibly not 
with even weight especially since the substrate is 
generally and not uniformly labelled and the per- 
centage retention of tritium during isomerization of 
intermediate epoxides to terminal phenols (NIH- 
shift, for a review see [l] ) may not be strictly 
206 
identical at different positions of the molecule al- 
though differences in relative retentions would be 
expected to be small. Pertinent results are labelled 
‘Overall’ in this study. Despite these limitations, the 
results will provide a valid measure of relative MO 
activities with respect to (different positions of) the 
benzo(a)pyrene molecule. For determination of EH 
with styrene oxide as a substrate, the more sensitive 
radiometric assay was used [ 171. Protein concentra- 
tions were estimated as described by Lowry et al. 
[ 181 using bovine serum albumin as a standard. The 
significance of differences between means was 
established using the student’s t-test [ 191. P < 0.05 
was chosen as the level of significance. Where increases 
in enzyme activity are referred to as ‘induction’ in 
this study, presence of higher levels of enzyme 
protein rather than presence of an activator or removal 
of an inhibitor was demonstrated by mixing enzyme 
preparations from controls and treated animals in 
various proportions which always resulted in activities 
corresponding to the sum of the two components. 
However, no specific underlying mechanism was 
established. 
3. Results and discussion 
EH activity of the fetal rat liver was significantly 
(although quite weakly) increased after transplacental 
treatment with phenobarbital (table 1). Interestingly, 
MO activity was also increased, as already observed 
by some workers [20] but not by others who used 
somewhat lower doses 1211. Similar requirements 
with respect to time and dosage of treatment, and 
similar magnitudes of increase enforced the view that 
possibly MO and EH induction were under a common 
biosynthetic control. However, pregnenolone 1 ICY- 
carbonitrile transplacentally induced EH significantly 
but only slightly while MO was greatly induced 
(table 1). These marked differences in relative in- 
creases may indicate a different control of EH and 
MO induction. On the other hand they may simply 
be due to different turnover rates. Use of 3-methyl- 
cholanthrene or benzo(a)pyrene as potential trans- 
placental inducers led to a complete dissociation, MO 
being greatly induced while EH remained unchanged 
(increased MO activities in fetal rat after transplac- 
ental treatment with polycyclic hydrocarbons have 
Volume 53, number 2 FEBS LETTERS 
Table 1 
Microsomal enzyme activities in fetal rat liver after transplacental treatment with potential inducers 
May 1975 
Treatment Mono-oxygenase Epoxide hydratase 
‘3-OHBP’a ‘OveralPa 
pmol OH-benz- % of con- dpm over blank/ % of con- nmol styrene % of con- 
pyrene/mg pro- trols mg protein per trols glycol /mg pro- trols 
tein per min mino tein per min 
None 6.0 * 1.6 100 f 27 1’ 200 + 150 100 f 12 0.87 f 0.07 
Phenobarbital: 
1 dayC - _ 1’ 310 * 110 109r 9 1.05 * 0.14 
2 daysC _ - 1’580 + 160 132 + 13 1.34 f 0.29 
3 daysC - _ 1’800 f llO* 150+ 9* 1.32 f 0.07* 
4 daysd 8.2 * 1.1 137r 18 2’ 060 + 270* 172 r 22* 1.24 r O.ll* 
Pregnenolone 16~ 
carbonitrile 
4 daysd 25.2 r 2.4* 420? 60* 3’ 410 + 330* 284 f 28* 1.27 * O.ll* 
3-Methylcholanthrene 
1 dayC 216.0 f 15* 3’ 600 + 250* 7’ 000 f 610* 583 f 51* 0.95 * 0.11 
Benzo(a)pyrene 
1 dayC 124.0 f 14* 2’ 060 ? 240* 3’ 890 f 170* 324 f 14* 0.84 * 0.13 
100 f 8 
121 f 16 
154 A 33 
152+ 8* 
143 f 12* 
146 + 12* 
109 + 13 
97 f 14 
Pregnant rats were treated intragastrally with 80 mg/kg of phenobarbital in water; 60 mg/kg of pregnenolone 16acarbonitrile in 
propane-l ,2-diol or 20 mg/kg of 3-methylcholanthrene or 60 mg/kg of benzo(a)pyrene in sunflower oil. No significant differences 
in enzyme activities were observed between untreated and vehicle-treated controls. All rats were killed 20 days after copulation 
which was always 24 hr after the last dose of potential inducer. Values represent means r S.E.M. of at least 4 determinations. 
a See text. 
b 1 pmol substrate = 330 dpm. 
c One dose daily. 
d Two doses daily. 
* Increase at the P < 0.05 level statistically significant. 
been observed [2 l-231 . Table 2 shows that this 
complete dissociation holds for any stage of onto- 
genetic development at which MO and EH activities 
can be measured without prior induction, that is 
from day 17 to 20 of fetal age. These increases in 
MO in contrast to unchanged EH levels were always 
observed 24 hr after treatment with the polycyclic 
hydrocarbon, still leaving the question open whether 
the dissociation referred to induction as such or 
possibly just to the time course of induction. Fig.1 
shows that during the entire time course of rise of 
MO activity and of its return to control levels EH 
activity remained unchanged. 
The great differences in MO induction with 
respect to ‘3-OHBP’ as compared to ‘Overall’ after 
transplacental treatment with 3-methylcholanthrene 
or benzo(a)pyrene (and, although to a smaller but 
still significant extent, also after pregnenolone 16a- 
carbonitrile) (tables 1 and 2, tig.l) indicate that more 
than one MO is involved in oxidative metabolism of 
benzo(a)pyrene and differentially measured with this 
dual assay, these different increases being explainable 
by a different control of induction or by a different 
turnover rate, either assumption being incompatible 
with one molecular species. 
Apart from other possible explanations, this selec- 
tivity of transplacental induction of MO under con- 
ditions not leading to changes in EH may possibly 
explain why carcinogenic polycyclic aromatic 
hydrocarbons which do not induce liver tumors in 
adult rats [24-261, where they induce both MO and 
EH, can do so transplacentally [27,28], inducing 
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.E MONOOXYGENASE EPOXIDE HYDRATASE 
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DAYS AFTER TRANSPLACENTAL TREATMENT WITH BENZPYRENE 
Fig.1. Time course of fetal liver enzyme activities after a single dose of benzotajpyrene. Pregnant rats were treated intragastrally 
with 60 mg/kg of benzotajpyrene in sunflower oil and were killed 0 (controls), 1, 2, 3 and 4 days thereafter which always was 
at 19 days of fetal age. The hatched areas below the zero line represent the experimental blank. ‘Overall’ monooxygenase 
activities are expressed in terms of dpm over blank/mg protein per min. 1 pmol benzpyrene (substrate) had 330 dpm. Values 
represent means f S.E.M. of at least 4 determinations. Epoxide hydratase activities after treatment were at the P < 0.05 level not 
significantly different from controls. 
in the fetal liver MO but not EH. Rates of hydration 
in control preparations even higher than those of MO 
after transplacental induction (tables 1 and 2, fig. 1) 
do not preclude this speculation since concentrations 
of metabolically produced unstable epoxides may be 
well below that required to saturate EH. Thus in vivo 
rates of hydration may be considerably slower than 
the ones determined in vitro under saturating condi- 
tions. 
It therefore appears that (at least) two MO’s are 
differentially involved in oxidative metabolism at 
different sites of the benzo(a)pyrene molecule, and 
that induction of EH, clearly, is not under common 
control with either of them. A selective induction 
of the inactivating EH should therefore not be in- 
trinsically impossible, although it might practically 
prove difficult due to the great ease of induction of 
MO [29-311. 
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